(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIAISON PLEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIAISON PLEX

ST13

US500000098062754

Class

1, 5, 9, 10

Filing

98062754

Registration

7972029

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/08/2025

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

06/28/2023

Registration date

10/07/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/07/2025

Last transaction

10/08/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

09

Owner location

SALUGGIA, IT

Examiner

GREEN,ASHLEY ELIZABETH

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

DIASORIN S.P.A.
L. C. (pessoa física)

Representatives

Ben Natter HAUG PARTNERS, LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in science; chemical diagnostic reagents for scientific purposes; Diagnostic preparationsother than for medical or veterinary purposes; Reagent bearing diagnostic strips for testing of infectious diseases and organic moleculesother than for medical or veterinary use; diagnostic testing materialsother than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparationschemical control solutions for in vitro diagnostic testingscreeningconfirmation and analysis for laboratory or research use; diagnostic reagents and chemical reagents for scientific or research purposes; solutions in the nature of chemical control solutions used in diagnostic test kits for laboratory or research purposes; Chemically treated non-medical test strips for laboratory or research purposes; diagnostic preparations for laboratory or research use; diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; diagnostic biomarkers for analyticalresearch and scientific use; diagnostic preparations for in vitro testing for scientific use; Nucleic acids; Nucleic acids for scientific purposes

Class 5

Medical diagnostic preparations for medical and veterinary purposes for the detection of infectious diseases; Medical diagnostic test reagents for testing body fluids for veterinary use; Medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; Diagnostic kits comprising medical diagnostic bioreagents for extractingtesting and analyzing body fluids; diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids for use in disease detectioninfectious diseasedetection of biological parameters; Diagnostic testing materials for medical usemedical diagnostic test strips for use in the field of infectious diseases and detection of biological parameters; Medical diagnostic test strips for blood analysis; Virus testing preparations for medical use; Medical diagnostic assays for medical use; In vitro medical diagnostic tests for use in disease testing; In vitro medical diagnostic assays for use in disease testing; In vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; in vitro medical diagnostic test strips for blood analysis; in vitro medical diagnostic reagents; medical diagnostics tests strips for the detectiondiagnosisscreeningconfirmation of viruses and infections; reagents and test strips for medical purposes for use in detecting the presence of nucleic acid targetsas indicators of diseases with such indicators being enzymesantigensantibodies and nucleic acids; immunoassay reagents for medical use; Biological and chemical preparations and reagents for medical or veterinary purposes for the detection of infectious diseases; biochemical preparations for medical or veterinary purposes for the detection of infectious diseases; bacterial preparations for medical and veterinary use; Nucleic acid sequences for medical and veterinary purposes; Test cartridges in the nature of medical diagnostic reagents for the detection of pathogens responsible for respiratory and gastrointestinal infection syndromes and for bacterial and fungal sepsis

Class 9

Downloadable computer software mobile applications for use in diagnosing individuals; Downloadable computer software for medical diagnostics and for operating diagnostic apparatus that is not for medical purpose; Testing machines and instruments for diagnostic purposesother than for medical useapparatuses composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected POC (Point of care) immunodiagnostic software platform for diagnostic research and scientific use; Downloadable computer software and hardware for the designcreation and control of tools for medical diagnostics; Downloadable software for data processing; data processing equipmentoptical readers for diagnostic purposes; PC tablets used for test and diagnostic purpose; Video monitors; Testing apparatus not for medical purposesapparatus for testing liquids and solids; measuring or testing machines and instruments for diagnostic purposeother than for medical useapparatus composed of PC tablets and optical readers for testing liquids and solids; research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids

Class 10

Diagnostic testing apparatus for medical purposes for testing biomarkers and biomolecules; Medical diagnostic apparatus for medical purposes; tools for medical diagnosticsmedical diagnostic apparatus for testing viruses and infectious disease; medical devices for diagnosing viruses; Electronic analyzers for bacterial identification for medical purposes; apparatus for taking blood samples; apparatus for taking body fluid samples; Point of Care (POC) diagnosticexaminationmonitoring equipmentrespiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes; diagnostic apparatus for the identification of virusbacterial infections and infectious diseases; Radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; laboratory apparatus for medical diagnostic purposes in the nature of cell analyzers used for the purpose of diagnosing viruses; medical diagnostic apparatus for testing for viruses; apparatus for DNA and RNA testing for medical purposes; Syringes for injections; hypodermic syringes for medical use; extraction medical syringes; disposable hypodermic syringes for medical use; medical syringe needles; Syringe needles for medical purposes; micro-needling needles for medical purposes; Medical diagnostic apparatus for the identification of pathogens responsible for syndromes of respiratory and gastrointestinal infections and for bacterial and fungal sepsis; Molecular platform designed for the detection of pathogens through multiplex PCR nucleic acid amplification technology; X-ray diagnostic apparatuses

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/03/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/19/2025

PUBO

PUBLISHED FOR OPPOSITION

08/19/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/13/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/09/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/08/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/12/2025

GNRT

NON-FINAL ACTION E-MAILED

05/12/2025

CNRT

NON-FINAL ACTION WRITTEN

05/12/2025

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/08/2025

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/12/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/23/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/23/2024

ALIE

ASSIGNED TO LIE

09/23/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/14/2024

GNRT

NON-FINAL ACTION E-MAILED

03/14/2024

CNRT

NON-FINAL ACTION WRITTEN

03/14/2024

DOCK

ASSIGNED TO EXAMINER

03/13/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/31/2023

NWAP

NEW APPLICATION ENTERED

07/01/2023

Continuous trademark protection

Get notified about every new filing that threatens LIAISON PLEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.